Back

A Single-Cell Peripheral Immune Atlas Spanning High-Risk Lesions to Invasive Breast Cancer in Black and White Women

Chen, F.; Ogayo, E. R.; Rahman, T.; Recko, A.; Starobinets, H.; Spasic, M.; Parsons, A. M.; Van Galen, P.; Mittendorf, E.; McAllister, S.

2026-05-07 cancer biology
10.64898/2026.05.04.722801 bioRxiv
Show abstract

Black women are at risk for breast cancer nearly a decade before women of other racial groups for unclear reasons. Because immune responses influence cancer initiation and progression, we performed single-cell RNA sequencing of peripheral blood mononuclear cells from non-Hispanic Black (NHB) and non-Hispanic White (NHW) women with high-risk breast lesions, ductal carcinoma in-situ, and invasive breast cancer. Race-associated transcriptional differences were observed across all disease states and were most pronounced in invasive disease. Computational analyses, supported by flow cytometric protein analysis, revealed enrichment of chronic inflammation, immune regulatory programs, and immune aging pathways in NHB cancer patients, particularly in monocytes, dendritic cells, CD4+ T cells, and B cells. From these data, we derived a population-level immune signature (IMM-POP) comprising genes differentially enriched in this subset of immune cells from NHB breast cancer patients. IMM-POP correlates with an immunosuppressive signature in external breast cancer datasets. We thus provide a single-cell peripheral immune atlas integrating race and breast disease state. SignificanceThis study revealed race-specific peripheral immunity features in precancerous and invasive breast cancers: Black patients exhibited features of chronic inflammation and immune aging compared with White patients, suggesting immune weathering and providing insights for studying early onset of breast cancer in Black patients.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
Cell Reports
1338 papers in training set
Top 3%
9.7%
2
Nature Communications
4913 papers in training set
Top 20%
9.7%
3
Science
429 papers in training set
Top 4%
8.1%
4
Nature
575 papers in training set
Top 4%
6.9%
5
Nature Cancer
35 papers in training set
Top 0.2%
4.7%
6
Cancer Discovery
61 papers in training set
Top 0.5%
4.2%
7
Nature Genetics
240 papers in training set
Top 2%
3.8%
8
Nature Cell Biology
99 papers in training set
Top 1%
3.8%
50% of probability mass above
9
Cell Reports Medicine
140 papers in training set
Top 2%
3.5%
10
Genome Medicine
154 papers in training set
Top 2%
3.5%
11
Developmental Cell
168 papers in training set
Top 6%
3.5%
12
Cell Genomics
162 papers in training set
Top 2%
3.5%
13
Cancer Research
116 papers in training set
Top 1%
3.5%
14
eLife
5422 papers in training set
Top 37%
2.0%
15
Journal of Experimental Medicine
106 papers in training set
Top 2%
2.0%
16
Science Translational Medicine
111 papers in training set
Top 2%
2.0%
17
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 31%
1.8%
18
Immunity
58 papers in training set
Top 2%
1.8%
19
Nature Medicine
117 papers in training set
Top 2%
1.7%
20
Cell
370 papers in training set
Top 12%
1.6%
21
Cancer Cell
38 papers in training set
Top 1%
1.3%
22
Cell Stem Cell
57 papers in training set
Top 2%
1.2%
23
Nature Aging
51 papers in training set
Top 1%
0.9%
24
Science Advances
1098 papers in training set
Top 26%
0.9%
25
Clinical Cancer Research
58 papers in training set
Top 2%
0.8%
26
Journal of Clinical Investigation
164 papers in training set
Top 6%
0.8%
27
Cell Systems
167 papers in training set
Top 12%
0.8%
28
Nature Metabolism
56 papers in training set
Top 3%
0.7%
29
The American Journal of Human Genetics
206 papers in training set
Top 4%
0.7%
30
Molecular Cell
308 papers in training set
Top 11%
0.7%